Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial)

OBJECTIVE: Proteome analyses in patients with newly diagnosed, untreated giant cell arteritis (GCA) have not been reported previously, nor are changes of protein expression upon treatment with glucocorticoids (GC) and/or tocilizumab (TCZ) known. The GUSTO trial allows to address these questions, pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Christ, Lisa, Gloor, Andrea D., Kollert, Florian, Gaber, Timo, Buttgereit, Frank, Reichenbach, Stephan, Villiger, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242646/
https://www.ncbi.nlm.nih.gov/pubmed/37287970
http://dx.doi.org/10.3389/fimmu.2023.1165758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242646/
https://www.ncbi.nlm.nih.gov/pubmed/37287970
http://dx.doi.org/10.3389/fimmu.2023.1165758

Ejemplares similares